Authors: Latchman, Y Wood, CR Chernova, T Chaudhary, D Borde, M Chernova, I Iwai, Y Long, AJ Brown, JA Nunes, R Greenfield, EA Bourque, K Boussiotis, VA Carter, LL Carreno, BM Malenkovich, N Nishimura, H Okazaki, T Honjo, T Sharpe, AH Freeman, GJ

Citation: Y. Latchman et al., PD-L2 is a second ligand for PD-I and inhibits T cell activation, NAT IMMUNOL, 2(3), 2001, pp. 261-268

Authors: McAdam, AJ Greenwald, RJ Levin, MA Chernova, T Malenkovich, N Ling, V Freeman, GJ Sharpe, AH

Citation: Aj. Mcadam et al., ICOS is critical for CD40-mediated antibody class switching, NATURE, 409(6816), 2001, pp. 102-105

Authors: McAdam, AJ Chang, TT Lumelsky, AE Greenfield, EA Boussiotis, VA Duke-Cohan, JS Chernova, T Malenkovich, N Jabs, C Kuchroo, VK Ling, V Collins, M Sharpe, AH Freeman, GJ

Citation: Aj. Mcadam et al., Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells, J IMMUNOL, 165(9), 2000, pp. 5035-5040

Authors: Freeman, GJ Long, AJ Iwai, Y Bourque, K Chernova, T Nishimura, H Fitz, LJ Malenkovich, N Okazaki, T Byrne, MC Horton, HF Fouser, L Carter, L Ling, V Bowman, MR Carreno, BM Collins, M Wood, CR Honjo, T

Citation: Gj. Freeman et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J EXP MED, 192(7), 2000, pp. 1027-1034